Purchase Order 75F40123P00175
Award Date 8/17/23
Potential Completion Date 11/17/23
Potential Value $211K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bohemia, NY 11716, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The $89,489.60 Firm Fixed Price Purchase Order is for the supply of bioreactor parts and accessories. The contract does not have a set-aside designation. Sartorius Stedim North America Inc. is a leading provider of laboratory...
- This is a $181,170.00 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The contract is for the provision of Sartorius bioreactor units and accessories. This contract does not have a set-aside designation. Sartorius Stedim North America Inc. is a critical supplier to various federal agencies, providing advanced laboratory equipment, consumables, and...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm fixed price purchase order to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft, to provide an AMBR15 analysis module equipped with BioPAT Spectro hardware and flow cell. The contract has a potential value of $90,507.50 and a completion date of November 17, 2023. No set-aside designation was used for this award. Sartorius Stedim North America Inc. is a...
- This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The $198,816.00 fixed-price contract is for maintenance on a Sartorius Biostat B-DCU II parallel bioreactor system. The contract has no set-aside designation and was awarded on December 20, 2018, with a completion date of January 1, 2022. Sartorius Stedim North America Inc. has...
- Sartorius Stedim North America, Inc. was awarded a $126,870 purchase order by the Department of Health and Human Services' Food and Drug Administration to provide bioreactor parts and components. As the prime contractor, Sartorius Stedim North America will deliver the requested biomanufacturing equipment components from its Bohemia, New York facility in support of the FDA's regulatory and research programs. The firm fixed price contract runs from August 2023 through September 2024. No set...
- This is a $210,267.91 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of off-line gas analyzers, on-line and integral nutrient analyzers, bioreactor probes, and accessories for a Sartorius BIOSTAT bioreactor system. This award does not have a set-aside designation. Sartorius Stedim North America...
- Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft, has been awarded a $46,330.00 firm fixed price purchase order contract by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center. The contract, which does not have a set-aside designation, is for the delivery of various laboratory equipment and consumables, including bioreactors, filtration systems, and analytical testing products, to support the...
- The Food and Drug Administration awarded a $86.8K firm fixed-price purchase order to Sartorius Stedim North America Inc. for operational parts and software updates to Biostat B-DCU II bioprocess control units equipped with BioPat analytics systems. The contract, awarded on September 17, 2019, with a completion date of January 30, 2020, represents a non-set-aside procurement for specialized biopharmaceutical manufacturing support equipment. Sartorius Stedim North America Inc., a subsidiary of...
- This is a $6,806 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of 01-GMP TPO, 50UG, a biopharmaceutical product or laboratory equipment, with a period of performance through April 17, 2025. Sartorius Stedim North America is a leading provider of laboratory equipment, consumables, and services supporting...
- This federal contract award to Sartorius Stedim North America Inc. is for the procurement of two AMBR 250 high throughput bioreactor systems for the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Production Program (VPP). The $4,507,574 firm fixed price purchase order requires delivery within 65 days. The bioreactor systems must meet specific technical requirements to support NIAID's mammalian cell culture research and development. This contract is not set aside for any...